Filgrastim Completed Phase 2 Trials for Malignant Neoplasm of Stomach / Adenocarcinomas of the Gastroesophageal Junction Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00515411Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma